A critical breakthrough in cancer research is occurring with the use of mini-antibodies to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several forms of malignancies, https://bookmarkassist.com/story21824904/vhh-fragments-reactivate-the-p53-protein-new-potential-pathway-for-tumor-treatment